Besides IRD, gene therapy has also been applied for treatment of age-related macular degeneration by inhibiting VEGF (Heier et al., 2017; Grishanin et al., 2019) or the complement cascade (Cashman et al., 2011). This evidence concerns the gene VEGFA and age-related macular degeneration.